ERAS Competitors & Alternatives
Compare Erasca Inc with similar stocks in the same industry
Biotechnology
ERAS
Main Stock$16.80
Tradestie Score
39
Market Cap
$626.91M
Analyst Upside
+43.5%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.54
|
$6.03B | - | 33 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.75
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$149.24
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$65.76
|
$5.80B | 95.9 | 35 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$308.81
|
$5.20B | 41.6 | 52 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$68.62
|
$4.94B | - | 41 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$64.91
|
$4.93B | - | 43 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$49.36
|
$4.84B | - | 43 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More ERAS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry